Innovative ETFs Channel Pfizer’s COVID-19 Pill Has Mixed Results for Healthcare ETFs By Max ChenNovember 5, 2021
Equity ETF Channel Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause By Ian YoungApril 13, 2021
Equity ETF Channel Johnson & Johnson, UnitedHealth Give Healthcare ETFs a Much Needed Bolster Shot By Max ChenOctober 15, 2019
Innovative ETFs Channel Potential Peanut Allergy Treatment Gives Pharma Company A Boost By Ian YoungSeptember 11, 2019
Beyond Basic Beta Channel 8 ETFs to Capture Opportunities in Healthcare Sector By Max ChenAugust 22, 2019
Thematic Investing Channel Johnson & Johnson Could Be A Good Bet Despite Opioid Lawsuit By Ian YoungJuly 8, 2019
Innovative ETFs Channel AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs By Max ChenJune 25, 2019
Beyond Basic Beta Channel 4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat By Ben HernandezApril 9, 2019
Equity ETFs Healthcare ETFs Looked Pale on Reports J&J Knew About Asbestos in Baby Powder By Max ChenDecember 14, 2018
